Literature DB >> 2290308

Circadian rhythm of interleukin-1 production of monocytes and the influence of endogenous and exogenous glucocorticoids in man.

P Zabel1, H J Horst, C Kreiker, M Schlaak.   

Abstract

We found a dose-dependent inhibition of spontaneous and LPS-induced IL-1 production of isolated human monocytes by methylprednisolone (MP) in vitro. Kinetic studies of spontaneous and LPS-induced IL-1 production of isolated monocytes of 10 normal individuals showed a synchronous circadian rhythm, with its maximum at 4:00 p.m. and its minimum at 4:00 a.m., which is most probably independent of the physiological circadian rhythm of cortisol levels because the IL-1 production was of the same value at the times of maximum and minimum cortisol levels. In contrast, in a patient with hypercortisolism and a preserved circadian rhythm of cortisol levels, we found the minimum of IL-1 production at 4:00 p.m., 8 hours after the maximum cortisol level was reached. Furthermore, in 7 patients with sarcoidosis both spontaneous and LPS-induced IL-1 production of isolated monocytes were significantly decreased 8 hours after the first injection of MP (1 mg/kg bw i.v.) compared to the values before MP administration. Our findings suggest a physiological circadian rhythm of spontaneous and LPS-induced IL-1 production of monocytes, independent of physiological cortisol levels, whereas unphysiological amounts of endogenous and exogenous glucocorticoids cause a substantial inhibition of IL-1 production with a latency time of 8 hours.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2290308     DOI: 10.1007/bf01796513

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  16 in total

1.  Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis.

Authors:  J A Eastgate; J A Symons; N C Wood; F M Grinlinton; F S di Giovine; G W Duff
Journal:  Lancet       Date:  1988-09-24       Impact factor: 79.321

2.  General presence of glucocorticoid receptors in mammalian tissues.

Authors:  P L Ballard; J D Baxter; S J Higgins; G G Rousseau; G M Tomkins
Journal:  Endocrinology       Date:  1974-04       Impact factor: 4.736

3.  Separation of leukocytes from blood and bone marrow. Introduction.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

4.  Isolation and characterization of lipocortin (lipomodulin).

Authors:  F Hirata; Y Notsu; R Yamada; Y Ishihara; Y Wano; I Kunos; G Kunos
Journal:  Agents Actions       Date:  1986-01

5.  Glucocorticoid-induced inhibition of T cell growth factor production. I. The effect on mitogen-induced lymphocyte proliferation.

Authors:  S Gillis; G R Crabtree; K A Smith
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

6.  Corticosteroid-interleukin 2 interactions: inhibition of binding of interleukin 2 to interleukin 2 receptors.

Authors:  H J Horst; H D Flad
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

7.  IFN-gamma and LPS overcome glucocorticoid inhibition of priming for superoxide release in human monocytes. Evidence that secretion of IL-1 and tumor necrosis factor-alpha is not essential for monocyte priming.

Authors:  S J Szefler; C E Norton; B Ball; J M Gross; Y Aida; M J Pabst
Journal:  J Immunol       Date:  1989-06-01       Impact factor: 5.422

8.  Interleukin 2 regulates expression of its receptor and synthesis of gamma interferon by human T lymphocytes.

Authors:  G H Reem; N H Yeh
Journal:  Science       Date:  1984-07-27       Impact factor: 47.728

9.  Interleukin 1 activity in the synovial fluid of patients with rheumatoid arthritis.

Authors:  A Fontana; H Hengartner; E Weber; K Fehr; P J Grob; G Cohen
Journal:  Rheumatol Int       Date:  1982       Impact factor: 2.631

10.  Release of interleukin-1 by alveolar macrophages of patients with active pulmonary sarcoidosis.

Authors:  G W Hunninghake
Journal:  Am Rev Respir Dis       Date:  1984-04
View more
  2 in total

1.  Glucocorticoids as cytokine inhibitors: role in neuroendocrine control and therapy of inflammatory diseases.

Authors:  G Fantuzzi; P Ghezzi
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711

2.  A mathematical model of the immune and neuroendocrine systems mutual regulation under the technogenic chemical factors impact.

Authors:  N V Zaitseva; D A Kiryanov; D V Lanin; V M Chigvintsev
Journal:  Comput Math Methods Med       Date:  2014-04-27       Impact factor: 2.238

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.